- Corporate Officers - M
- Mullen James C
Insider Trading History of Mullen James C
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Mullen James C since 2006.
This trader's CIK number is 1226288.
At the time of last reporting, Mullen James C was the CEO of Editas Medicine, Inc.. (stock ticker symbol EDIT).
Also see all insider trading activities at Editas Medicine, Inc..
Note that in the past
MULLEN JAMES C also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Patheon Inc (PTI) by Mullen James C
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2012 | PTI | 592,659 | $1,005,265 | 0 | $0 | 1,000,000 | $2,640,000 |
| 2011 | PTI | 1,216,769 | $1,986,282 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Biogen Inc. (BIIB) by Mullen James C
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2010 | BIIB | 0 | $0 | 440,500 | $26,415,645 | 440,500 | $22,068,966 |
| 2009 | BIIB | 0 | $0 | 147,037 | $7,378,316 | 26,666 | $0 |
| 2008 | BIIB | 0 | $0 | 758,750 | $49,143,648 | 785,417 | $32,460,482 |
| 2007 | BIIB | 0 | $0 | 0 | $0 | 26,667 | $0 |
| 2006 | BIIB | 0 | $0 | 480,175 | $24,164,197 | 480,175 | $17,074,235 |
Yearly summary of insider trading at Insulet Corp (PODD) by Mullen James C
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2017 | PODD | 2,500 | $168,632 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Perkinelmer Inc (PKI) by Mullen James C
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2014 | PKI | 0 | $0 | 21,843 | $955,172 | 21,843 | $521,610 |
| 2013 | PKI | 0 | $0 | 6,440 | $195,196 | 6,440 | $139,554 |
| 2012 | PKI | 0 | $0 | 5,865 | $157,481 | 5,865 | $116,537 |
| 2010 | PKI | 0 | $0 | 30,000 | $720,000 | 30,000 | $595,200 |
Yearly summary of insider trading at Editas Medicine, Inc. (EDIT) by Mullen James C
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2022 | EDIT | 0 | $0 | 36,504 | $983,964 | 0 | $0 |
| 2021 | EDIT | 25,000 | $1,156,800 | 13,805 | $525,031 | 0 | $0 |
| 2018 | EDIT | 10,000 | $380,250 | 0 | $0 | 0 | $0 |
Insider trading activities at 5 companies by Mullen James C:
1. Patheon Inc (PTI)
2. Biogen Inc. (BIIB)
3. Insulet Corp (PODD)
4. Perkinelmer Inc (PKI)
5. Editas Medicine, Inc. (EDIT)
Table 1. Insider trading of Patheon Inc (PTI) by Mullen James C
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2012-12-21 | PTI | Option Ex | 1,000,000 | 2.64 | 2,640,000 |
| 2012-03-16 | PTI | Buy | 5,000 | 1.88 | 9,400 |
| 2012-03-19 | PTI | Buy | 194,759 | 1.86 | 362,251 |
| 2012-03-13 | PTI | Buy | 800 | 1.67 | 1,336 |
| 2012-03-14 | PTI | Buy | 1,400 | 1.70 | 2,380 |
| 2012-03-09 | PTI | Buy | 15,300 | 1.75 | 26,775 |
| 2012-03-05 | PTI | Buy | 9,500 | 1.73 | 16,435 |
| 2012-02-29 | PTI | Buy | 48,400 | 1.97 | 95,348 |
| 2012-02-27 | PTI | Buy | 88,500 | 1.80 | 159,300 |
| 2012-02-22 | PTI | Buy | 6,000 | 1.71 | 10,260 |
| 2012-02-23 | PTI | Buy | 19,000 | 1.71 | 32,490 |
| 2012-02-21 | PTI | Buy | 8,700 | 1.68 | 14,616 |
| 2012-02-17 | PTI | Buy | 10,600 | 1.63 | 17,278 |
| 2012-02-13 | PTI | Buy | 7,000 | 1.54 | 10,780 |
| 2012-02-10 | PTI | Buy | 61,800 | 1.44 | 88,992 |
| 2012-02-09 | PTI | Buy | 115,900 | 1.36 | 157,624 |
| 2011-10-07 | PTI | Buy | 682,590 | 1.40 | 955,625 |
| 2011-06-16 | PTI | Buy | 27,500 | 2.18 | 59,950 |
| 2011-06-17 | PTI | Buy | 10,279 | 2.24 | 23,024 |
| 2011-06-14 | PTI | Buy | 437,100 | 1.89 | 826,119 |
| 2011-06-15 | PTI | Buy | 59,300 | 2.05 | 121,564 |
Table 2. Insider trading of Biogen Inc. (BIIB) by Mullen James C
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2010-03-19 | BIIB | Option Ex | 334,221 | 50.44 | 16,858,107 |
| 2010-03-22 | BIIB | Option Ex | 106,279 | 49.03 | 5,210,859 |
| 2010-03-22 | BIIB | Sale | 106,279 | 59.95 | 6,371,744 |
| 2010-03-19 | BIIB | Sale | 334,221 | 59.97 | 20,043,901 |
| 2009-12-16 | BIIB | Sale | 147,037 | 50.18 | 7,378,316 |
| 2009-02-07 | BIIB | Option Ex | 26,666 | .00 | 0 |
| 2008-04-15 | BIIB | Sale | 12,800 | 64.95 | 831,360 |
| 2008-04-15 | BIIB | Option Ex | 12,800 | 44.59 | 570,752 |
| 2008-04-11 | BIIB | Sale | 197,315 | 65.09 | 12,843,036 |
| 2008-04-11 | BIIB | Sale | 195,162 | 64.83 | 12,651,962 |
| 2008-04-11 | BIIB | Sale | 102,019 | 64.57 | 6,587,162 |
| 2008-04-11 | BIIB | Sale | 121,157 | 64.39 | 7,801,056 |
| 2008-04-11 | BIIB | Sale | 73,927 | 64.17 | 4,743,969 |
| 2008-04-11 | BIIB | Option Ex | 745,750 | 42.75 | 31,880,812 |
| 2008-04-14 | BIIB | Sale | 200 | 64.95 | 12,990 |
| 2008-04-14 | BIIB | Option Ex | 200 | 44.59 | 8,918 |
| 2008-04-11 | BIIB | Sale | 56,170 | 65.38 | 3,672,113 |
| 2008-02-07 | BIIB | Option Ex | 26,667 | .00 | 0 |
| 2007-02-07 | BIIB | Option Ex | 26,667 | .00 | 0 |
| 2006-11-27 | BIIB | Sale | 12,500 | 50.99 | 637,325 |
| 2006-11-27 | BIIB | Option Ex | 12,500 | 36.09 | 451,125 |
| 2006-11-20 | BIIB | Option Ex | 159,000 | 36.09 | 5,738,310 |
| 2006-11-20 | BIIB | Sale | 159,000 | 51.25 | 8,148,432 |
| 2006-11-16 | BIIB | Sale | 229,877 | 49.96 | 11,483,965 |
| 2006-11-17 | BIIB | Sale | 70,123 | 49.95 | 3,502,643 |
| 2006-11-16 | BIIB | Option Ex | 229,877 | 35.76 | 8,219,252 |
| 2006-11-17 | BIIB | Option Ex | 70,123 | 36.09 | 2,530,739 |
| 2006-04-28 | BIIB | Option Ex | 8,675 | 15.54 | 134,809 |
| 2006-04-28 | BIIB | Sale | 8,675 | 45.17 | 391,832 |
Table 3. Insider trading of Insulet Corp (PODD) by Mullen James C
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2017-11-13 | PODD | Buy | 2,500 | 67.45 | 168,632 |
Table 4. Insider trading of Perkinelmer Inc (PKI) by Mullen James C
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2014-11-14 | PKI | Option Ex | 8,892 | 26.49 | 235,549 |
| 2014-11-14 | PKI | Sale | 8,892 | 43.73 | 388,838 |
| 2014-02-07 | PKI | Sale | 12,951 | 43.73 | 566,334 |
| 2014-02-07 | PKI | Option Ex | 12,951 | 22.09 | 286,061 |
| 2013-04-30 | PKI | Option Ex | 6,440 | 21.67 | 139,554 |
| 2013-04-30 | PKI | Sale | 6,440 | 30.31 | 195,196 |
| 2012-02-21 | PKI | Sale | 5,865 | 26.85 | 157,481 |
| 2012-02-21 | PKI | Option Ex | 5,865 | 19.87 | 116,537 |
| 2010-11-04 | PKI | Option Ex | 10,000 | 19.84 | 198,400 |
| 2010-11-04 | PKI | Sale | 10,000 | 24.00 | 240,000 |
| 2010-11-04 | PKI | Option Ex | 10,000 | 19.84 | 198,400 |
| 2010-11-04 | PKI | Sale | 10,000 | 24.00 | 240,000 |
| 2010-11-04 | PKI | Option Ex | 10,000 | 19.84 | 198,400 |
| 2010-11-04 | PKI | Sale | 10,000 | 24.00 | 240,000 |
Table 5. Insider trading of Editas Medicine, Inc. (EDIT) by Mullen James C
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2022-01-03 | EDIT | Sale | 18,252 | 26.95 | 491,982 |
| 2022-01-03 | EDIT | Sale | 18,252 | 26.95 | 491,982 |
| 2021-10-18 | EDIT | Sale | 13,805 | 38.03 | 525,031 |
| 2021-03-02 | EDIT | Buy | 25,000 | 46.27 | 1,156,800 |
| 2018-05-18 | EDIT | Buy | 10,000 | 38.02 | 380,250 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Mullen James C
(CEO of Editas Medicine, Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.